Marijuana legalization in Idaho had to bear the brunt of the coronavirus pandemic. The lockdown forced the state to suspend its medical marijuana campaign. The group responsible for the campaign, the ICC (or the Idaho Cannabis Coalition), failed to collect the required signatures before the May 1 deadline. However, a recent federal court ruling for a separate initiative in the state might have sparked some hopes.
Since mid-March, Cannabis stocks have rebounded 79% from the record low set by the New Cannabis Ventures Global Cannabis Stock Index, yet they remain down 28% in 2020 and 83% since early 2018, days after California legalized cannabis for adult-use.
Some analysts speculate that a majority of cannabis purchases in California still occur in the illicit market.
Newly-elected California Gov. Gavin Newsom’s state budget shows that by the end of June the state expects to collect just $355 million in cannabis taxes, about half of what was previously projected, according to a MarketWatch report.
The Hawai‘i House of Representatives on Friday passed a bill legalizing the growing, processing, and sale of industrial hemp in Hawai‘i.
It passed the Senate on Wednesday unanimously, with Senators Les Ihara, Clarence K. Nishihara, and Laura H. Thielen expressing reservations. The legislation now goes to Governor David Ige to sign into law.
The potential of medical marijuana is widely known, not only in Canada and the U.S., but also globally. Many patients find that medical cannabis has helped them with certain health issues where conventional medicine has failed, including chronic pain, post-traumatic stress disorder (PTSD), Crohn's disease, and anxiety.
As an increasing number of states reduce the penalties for the possession and use of marijuana, a new movement to legalize the plant slowly gains momentum. Only this time, people aren’t merely advocating health and recreational benefits, but economic growth as well.
After being fired from his last two jobs, Canadian entrepreneur Bruce Linton is back with a new venture and a new goal: to disrupt the industrial supply chain.
Known as slotting fees, the practice requires brands to pay anywhere from $500 to $15,000 a month for premium space on cannabis retailers' shelves.
As more brands enter the marijuana products marketplace, competition for retail shelf space in key adult-use markets such as Colorado and Washington state is intensifying.
